{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:22:13Z","timestamp":1774974133875,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12863-0","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:24:48Z","timestamp":1772040288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HBsAg loss in recipients with chronic hepatitis B after allogeneic hematopoietic stem-cell transplantation: a retrospective cohort study exploring kinetic dynamics"],"prefix":"10.1186","volume":"26","author":[{"given":"Qiannan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijuan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengbin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9444-3678","authenticated-orcid":false,"given":"Yingli","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"12863_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"Y-C Hsu","year":"2023","unstructured":"Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20:524\u201337. https:\/\/doi.org\/10.1038\/s41575-023-00760-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12863_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","unstructured":"Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8:879\u2013907. https:\/\/doi.org\/10.1016\/S2468-1253(23)00197-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"12863_CR3","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jhep.2023.06.002","volume":"79","author":"MG Ghany","year":"2023","unstructured":"Ghany MG, Buti M, Lampertico P, Lee HM. 2022 AASLD-EASL HBV-HDV treatment Endpoints Conference faculty. Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV treatment Endpoints Conference. J Hepatol. 2023;79:1254\u201369. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.002.","journal-title":"J Hepatol"},{"key":"12863_CR4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.14218\/JCTH.2023.00320","volume":"11","author":"H You","year":"2023","unstructured":"You H, Wang F, Li T, Xu X, Sun Y, Nan Y, et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J Clin Transl Hepatol. 2023;11:1425\u201342. https:\/\/doi.org\/10.14218\/JCTH.2023.00320.","journal-title":"J Clin Transl Hepatol"},{"key":"12863_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/v11111049","volume":"11","author":"G Gentile","year":"2019","unstructured":"Gentile G, Antonelli G. HBV reactivation in patients undergoing hematopoietic stem cell transplantation: a narrative review. Viruses. 2019;11:1049. https:\/\/doi.org\/10.3390\/v11111049.","journal-title":"Viruses"},{"key":"12863_CR6","doi-asserted-by":"publisher","first-page":"610500","DOI":"10.3389\/fimmu.2020.610500","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu Y, Huang H, Luo Y. Management of hepatitis B virus in allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:610500. https:\/\/doi.org\/10.3389\/fimmu.2020.610500.","journal-title":"Front Immunol"},{"key":"12863_CR7","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1016\/S2352-3018(24)00090-0","volume":"11","author":"M Salgado","year":"2024","unstructured":"Salgado M, G\u00e1lvez C, Nijhuis M, Kwon M, Cardozo-Ojeda EF, Badiola J, et al. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study. Lancet HIV. 2024;11:e389\u2013405. https:\/\/doi.org\/10.1016\/S2352-3018(24)00090-0.","journal-title":"Lancet HIV"},{"key":"12863_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","volume":"29","author":"B-E Jensen","year":"2023","unstructured":"Jensen B-E, Knops E, Cords L, L\u00fcbke N, Salgado M, Busman-Sahay K, et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation. Nat Med. 2023;29:583\u201387. https:\/\/doi.org\/10.1038\/s41591-023-02213-x.","journal-title":"Nat Med"},{"key":"12863_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41409-022-01880-7","volume":"58","author":"X Sun","year":"2023","unstructured":"Sun X, Fu H, Wang C, Zhang Y, Han W, Chen H, et al. Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection. Bone Marrow Transpl. 2023;58:265\u201372. https:\/\/doi.org\/10.1038\/s41409-022-01880-7.","journal-title":"Bone Marrow Transpl"},{"key":"12863_CR10","doi-asserted-by":"publisher","first-page":"106290","DOI":"10.1016\/j.isci.2023.106290","volume":"26","author":"J Ren","year":"2023","unstructured":"Ren J, Lin Q, Chen Q, Xu J, Chen D, Chen R, et al. Adoptive immune transfer from donors offers anti-HBV protection to HBsAb-negative patients after allo-HSCT. iScience. 2023;26:106290. https:\/\/doi.org\/10.1016\/j.isci.2023.106290.","journal-title":"iScience"},{"key":"12863_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s12072-021-10239-x","volume":"15","author":"G Lau","year":"2021","unstructured":"Lau G, Yu M-L, Wong G, Thompson A, Ghazinian H, Hou J-L, et al. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. Hepatol Int. 2021;15:1031\u201348. https:\/\/doi.org\/10.1007\/s12072-021-10239-x.","journal-title":"Hepatol Int"},{"key":"12863_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","volume":"8","author":"F Cui","year":"2023","unstructured":"Cui F, Blach S, Manzengo Mingiedi C, Gonzalez MA, Sabry Alaama A, Mozalevskis A, et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 2023;8:332\u201342. https:\/\/doi.org\/10.1016\/S2468-1253(22)00386-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"12863_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jhep.2024.07.018","volume":"82","author":"H-C Mon","year":"2025","unstructured":"Mon H-C, Lee P-C, Hung Y-P, Hung Y-W, Wu C-J, Lee C-J, et al. Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy. J Hepatol. 2025;82:51\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2024.07.018.","journal-title":"J Hepatol"},{"key":"12863_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12072-016-9747-0","volume":"11","author":"CH Jun","year":"2017","unstructured":"Jun CH, Kim BS, Oak CY, Lee DH, Cho E, Cho SB, et al. HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea. Hepatol Int. 2017;11:87\u201395. https:\/\/doi.org\/10.1007\/s12072-016-9747-0.","journal-title":"Hepatol Int"},{"key":"12863_CR15","doi-asserted-by":"publisher","unstructured":"Audsley J, Avihingsanon A, Li X, Edwards R, Jackson K, Warner N, et al. Kinetics and predictors of hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV and chronic HBV coinfection. Clin Infect Dis. 2025;ciaf281. https:\/\/doi.org\/10.1093\/cid\/ciaf281","DOI":"10.1093\/cid\/ciaf281"},{"key":"12863_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/pathogens14010008","volume":"14","author":"S-W Huang","year":"2024","unstructured":"Huang S-W, Long H, Huang J-Q. Surveillance following hepatitis B surface antigen loss: an issue requiring attention. Pathogens. 2024;14:8. https:\/\/doi.org\/10.3390\/pathogens14010008.","journal-title":"Pathogens"},{"key":"12863_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04730-6","author":"Y Wu","year":"2022","unstructured":"Wu Y, Chen Y, Zhu P, Ye B, Lu Y, Shi J, et al. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg\u2011positive recipients following allogeneic hematopoietic stem cell transplantation: a multi\u2011institutional experience from an HBV endemic area. Ann Hematol. 2022. https:\/\/doi.org\/10.1007\/s00277-021-04730-6.","journal-title":"Ann Hematol"},{"key":"12863_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jhep.2019.02.016","volume":"70","author":"FJ Jacobi","year":"2019","unstructured":"Jacobi FJ, Wild K, Smits M, Zoldan K, Csernalabics B, Flecken T, et al. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection. J Hepatol. 2019;70:1103\u201313. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.016.","journal-title":"J Hepatol"},{"key":"12863_CR19","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jhep.2022.05.041","volume":"77","author":"RC Hoogeveen","year":"2022","unstructured":"Hoogeveen RC, Dijkstra S, Bartsch LM, Drescher HK, Aneja J, Robidoux MP, et al. Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen+ infection. J Hepatol. 2022;77:1276\u201386. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.041.","journal-title":"J Hepatol"},{"key":"12863_CR20","doi-asserted-by":"publisher","first-page":"1130485","DOI":"10.3389\/fcimb.2023.1130485","volume":"13","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wang H, Jin Y, Zhou N, Sun L, Wu H, et al. Incidence and predictors of HBV functional cure in patients with HIV\/HBV coinfection: a retrospective cohort study. Front Cell Infect Microbiol. 2023;13:1130485. https:\/\/doi.org\/10.3389\/fcimb.2023.1130485.","journal-title":"Front Cell Infect Microbiol"},{"key":"12863_CR21","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/hep.29022","volume":"65","author":"W-K Seto","year":"2017","unstructured":"Seto W-K, Chan T-Y, Hwang Y-Y, Wong D-H, Fung J, Liu K-H, et al. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: a prospective study. Hepatology. 2017;65:1451\u201361. https:\/\/doi.org\/10.1002\/hep.29022.","journal-title":"Hepatology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12863-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:26:50Z","timestamp":1774967210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12863-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12863"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12863-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This cohort study was conducted in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards and was approved by the Ethics Committee of the First Affiliated Teaching Hospital of Xi\u2019an Jiaotong University (No. XJTU1AF2022LSK-330). Written informed consent was obtained from the patients and\/or the legal guardian of deceased patients for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all patients or their family members.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"688"}}